Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-27

  Kao, Yung Hsiang ^a,b,c   Steinberg, Jeffrey D ^d   Tay, Young Soon ^a   Lim, Gabriel K Y ^a   Yan, Jianhua ^e   Townsend, David W ^e   Budgeon, Charley ^b,f   Boucek, Jan A ^b   Francis, Roslyn J ^b   Cheo, Timothy S T ^g   Burgmans, Mark C ^a   Irani, Farah G ^a   Lo, Richard H G ^a   Tay, Kiang Hiong ^a   Tan, Bien Soo ^a   Chow, Pierce K H ^a,h,i   Satchithanantham, Somanesan ^a   Tan, Andrew E H ^a   Ng, David C E ^a   Goh, Anthony S W ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d AGENCY FOR SCIENCE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g TAN TOCK SENG HOSPITAL   (Singapore)

^h DIVISION OF MEDICAL ONCOLOGY   (Singapore)

ⁱ DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Dose volume histogram; PET CT; Predictive dosimetry; Selective internal radiation therapy; Voxel dosimetry; Yttrium 90 radioembolization

Indexed keywords

LUTETIUM; MACROSALB TC 99M; UNCLASSIFIED DRUG; YTTRIUM 90; YTTRIUM 90 RESIN MICROSPHERE;

ARTICLE; ARTIFICIAL EMBOLISM; ASYMPTOMATIC DISEASE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOSIMETRY; DUODENITIS; FEASIBILITY STUDY; FOLLOW UP; GASTRITIS; HUMAN; IMAGING PHANTOM; LIVER CELL CARCINOMA; NEPHROTOXICITY; PORTAL VEIN TUMOR THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; POSTRADIOEMBOLIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ABSORPTION; RADIATION DOSE; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH ULCER; TUMOR PREDICTIVE DOSIMETRY; TUMOR THROMBUS; TUMOR VOLUME; VEIN THROMBOSIS; VISCERAL METASTASIS;

EID: 84881233555     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-57     Document Type: Article

References (40)

1. Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, Takano A, Burgmans MC, Irani FG, Teo TKB, Yeow TN, Gogna A, Lo RHG, Tay KH, Tan BS, Chow PKH, Satchithanantham S, Tan AEH, Ng DCE, Goh ASW: Post-radioembolization yttrium-90 PET/CT-part 1: diagnostic reporting. EJNMMI Research.
2. Salem R, Lewandowski RJ, Gates VL, Nutting CW, Murthy R, Rose SC, Soulen MC, Geschwind JF, Kulik L, Kim YH, Spreafico C, Maccauro M, Bester L, Brown DB, Ryu RK, Sze DY, Rilling WS, Sato KT, Sangro B, Bilbao JI, Jakobs TF, Ezziddin S, Kulkarni S, Kulkarni A, Liu DM, Valenti D, Hilgard P, Antoch G, Muller SP, Alsuhaibani H, et al: Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol 2011, 22:265-278.
3. Kao YH: Results confounded by a disregard for basic dose-response radiobiology. J Nucl Med 2013. doi:10.2967/jnumed.113.122846.
4. Kao YH, Tan EH, Ng CE, Goh SW: Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. Ann Nucl Med 2011, 25:455-461.
5. Kao YH, Tan EH, Teo TK, Ng CE, Goh SW: Imaging discordance between hepatic angiography versus Tc-99m-MAA SPECT/CT: a case series, technical discussion and clinical implications. Ann Nucl Med 2011, 25:669-676.
6. 90Y radioembolization. J Nucl Med 2012, 53:559-566.
7. 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 2011, 38:4824-4845.
8. Lau WY, Kennedy AS, Kim YH, Lai HK, Lee RC, Leung TW, Liu CS, Salem R, Sangro B, Shuter B, Wang SC: Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys 2012, 82:401-407.
9. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, Brans B, Lambert B, Konijnenberg M, Borson-Chazot F, Tennvall J, Luster M, Therapy, Oncology and Dosimetry Committees: EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 2011, 38:1393-1406.
10. Lau WY, Leung TW, Ho S, Chan M, Leung NW, Lin J, Metreweli C, Li AK: Diagnostic pharmaco-scintigraphy with hepatic intra-arterial technetium-99m macroaggregated albumin in the determination of tumour to non-tumour uptake ratio in hepatocellular carcinoma. Br J Radiol 1994, 67:136-139.
11. 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004, 60:1552-1563.
12. Van de Wiele C, Maes A, Brugman E, D'Asseler Y, De Spiegeleer B, Mees G, Stellamans K: SIRT of liver metastases: physiological and pathophysiological considerations. Eur J Nucl Med Mol Imaging 2012, 39:1646-1655.
13. Ho S, Lau WY, Leung TW, Chan M, Ngar YK, Johnson PJ, Li AK: Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996, 23:947-952.
14. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK: Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997, 24:293-298.
15. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, Hendlisz A: Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres. Phys Med Biol 2008, 53:6591-6603.
16. Campbell JM, Wong CO, Muzik O, Marples B, Joiner M, Burmeister J: Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patientspecific method using single photon emission computed tomography and positron emission tomography. Int J Radiat Oncol Biol Phys 2009, 74:313-320.
17. Jiang M, Fischman A, Nowakowski FS, Heiba S, Zhuangyu Z, Knesaurek K, Weintraub J, Machac J: Segmental perfusion differences on paired Tc-99m macroaggregated albumin (MAA) hepatic perfusion imaging and yttrium-90 (Y-90) bremsstrahlung imaging studies in SIR-Sphere radioembolization: associations with angiography. J Nucl Med Radiat Ther 2012, 3:122.
18. Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A, Sposito C, Morosi C, Civelli E, Lanocita R, Camerini T, Bampo C, Bhoori S, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E: Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Q J Nucl Med Mol Imaging 2011, 55:168-197.
19. 90Y-loaded glass microspheres: preliminary results. J Nucl Med 2012, 53:255-263.
20. 90Y TOF PET-based dosimetry in liver metastasis therapy using SIRSpheres. Eur J Nucl Med Mol Imaging 2010, 37:1654-1662.
21. Walrand S, Lhommel R, Goffette P, Van den Eynde M, Pauwels S, Jamar F: Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. EJNMMI Res 2012, 2:20.
22. 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med 2006, 47:1209-1211.
23. 90Y-labeled SIR-Spheres using a nondestructive spectroscopic assay. Med Phys 2008, 35:1278-1279.
24. Boucek JA, Kao YH, Francis RJ: Yttrium-90 PET/CT voxel dosimetry. Western Australia, Australia: Department of Nuclear Medicine, Sir Charles Gairdner Hospital.
25. Boucek JA, Francis RJ, Jones CG, Khan N, Turlach BA, Green AJ: Assessment of tumour response with (18)F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax-a phantom study. Phys Med Biol 2008, 53:4213-4230.
26. Stabin MG, Eckerman KF, Ryman JC, Williams LE: Bremsstrahlung radiation dose in yttrium-90 therapy applications. J Nucl Med 1994, 35:1377-1380.
27. Browne E, Firestone RB: Table of Radioactive Isotopes. New York: Wiley; 1986.
28. Lencioni R, Llovet JM: Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010, 30:52-60.
29. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO: Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010, 76(Suppl):S10-S19.
30. Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M: Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010, 76(Suppl):S101-S107.
31. Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, Ferrer L, Barbet J, Schoenahl F, Kraeber-Bodéré F: Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013, 3:11.
32. 90Y PET. J Nucl Med 2010, 51:1969-1973.
33. Bilbao JI, de Martino A, de Luis E, Díaz-Dorronsoro L, Alonso-Burgos A, Martínez de la Cuesta A, Sangr B, García de Jalón JA: Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 2009, 32:727-736.
34. 90Y-SIR spheres: radiobiologic considerations. J Nucl Med 2010, 51:1377-1385.
35. 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun 2012, 33:633-640.
36. 90Y-microspheres. J Nucl Med 2011, 52:1930-1937.
37. Sirtex Technology Pty Ltd: Pilot study of selective internal radiation therapy (SIRT) with yttrium-90 resin microspheres (SIR-Spheres microspheres) in patients with renal cell carcinoma (STX0110, "RESIRT"). Trial ID ACTRN1261000069005. http://australiancancertrials.gov.au./.
38. Hamoui N, Gates VL, Gonzalez J, Lewandowski RJ, Salem R: Radioembolization of renal cell carcinoma using yttrium-90 microspheres. J Vasc Interv Radiol 2013, 24:298-300.
39. Goedicke A, Berker Y, Verburg F, Behrendt F, Winz O, Mottaghy F: Study-parameter impact in quantitative 90-yttrium PET imaging for radioembolization treatment monitoring and dosimetry. IEEE Trans Med Imaging 2013, 32:485-492.
40. Elschot M, Vermolen BJ, Lam MG, de Keizer B, van den Bosch MA, de Jong HW: Quantitative comparison of PET and bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS One 2013, 8:e55742.